Japan's new regulations allow for conditional release of a treatment DURING phase II trials. Keep your fingers crossed Shiseido takes advantage of this... if this happens you'll soon be able to have the life you deserve![]()
5 years... What a terrible thing. Best case scenario is they show all the details on paper and then rougue clinics are able to do this in USA. They're in Japan so they will probably do the stem cell fast track route of phase 2.
Regardless of the time, if we don't help out, it will be like 10 more years. Let's not be overly selfish and think only of ourselves, but also for future generations.
:salut:5 years... What a terrible thing. Best case scenario is they show all the details on paper and then rougue clinics are able to do this in USA. They're in Japan so they will probably do the stem cell fast track route of phase 2.
Regardless of the time, if we don't help out, it will be like 10 more years. Let's not be overly selfish and think only of ourselves, but also for future generations.
Regardless of the time, if we don't help out, it will be like 10 more years. Let's not be overly selfish and think only of ourselves, but also for future generations.
You are very optimistic
I know some doctors who do not expect a cure for hair loss for at least 20-25 years.
You are very optimistic
I know some doctors who do not expect a cure for hair loss for at least 20-25 years.
You're right, no one can estimate that far ahead, specially with the biotechs.thats just wonderful... but how on earth can they make such an estimate? 20-25 yrs is a very long time, it should really not take that long
You're right, no one can estimate that far ahead, specially with the biotechs.
I understand that people have high expectations from stem cell treatment, experiments, trials..
But unfortunately the only solution for baldness is hair cloning and scientists are at the very beginning of this treatment.
As far as I can tell, both RepliCel's RCH and Histogen's HSC are "the cure". Histogen is more efficient (i.e. only one session for full regrowth, independent of how bald you are as it seems), but its safety profile may be not as good (Wnt risks - I still have to dig into that) and, most importantly, we don't even know when HSC will be available. Given how they don't even have a starting date for their phase 3 trials, this could be anywhere bweteen "in 6 years" and "in 15 years".
RepliCel's RCH, on the other hand, definitely has no safety problems (still need to check whether HSC has) and it is closer to actually being available. Last estimate was Q4 2019. On the other hand, you might need multiple treatments but they're currently finding out in their Phase 3 trials. In Phase 2, they managed to give 11 to 14% regrowth on average - but with a single injection, which is quite impressive. In Phase 3, they now try a 90 injection protocol. Some investment analyst said that 50% regrowth in one treatment session is realistic, so - if his info, which was before Phase 3 though - is correct, you would need at most two treatment sessions. If the 90 injection protocol turns out better than expected, RCH might be just as good as HSC in terms of regrowth.
Nope, you got it wrong. Histogen injects a compound ("HSC") whose most active ingredient is Wnt7, a pluripotent cell growth factor. It makes the cells in hair follicles, which determine a hair's length and width, regenerate. These cells are lost during Androgenetic Alopecia/male pattern baldness due to PGD2-induced apoptosis. Problem with Wnt7 is that its effects don't only stimulate the growth of good cells, but also of bad cells, aka cancer. problem is that nobody knows how big the chance to develop cancer are. It could by miniscule (e.g., below 0.1%), or it could be considerable. Nobody knows as of now. But HSC regrows a full head of hair in almost no time.help me get this straight.
histogen = stem cell injection to scalp and rejuvenating dormant follicles.
replicell = getting donor strands cloning them and transplanting them in bald spots.
if I got it right, then it is my opinion that histogen is the better option.